# Pliant Therapeutics, Inc.: Form 10-K/A for the period ended Dec 31, 2021

- Company: [Pliant Therapeutics, Inc.](/companies/plrx.md) (CIK 1746473)
- Form: 10-K/A
- Filed: 2022-03-01
- Accepted by EDGAR: Mar 1, 2022, 17:26 ET
- Period: 2021-12-31
- Accession: 0001193125-22-061695
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1746473/000119312522061695/d281943d10ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1746473/000119312522061695/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1746473/000119312522061695/d281943d10ka.htm

Filed Mar 1, 2022.
Source: SEC EDGAR, the filing index for accession 0001193125-22-061695. Last ingested by Listed: Nov 13, 2026, 15:38 ET. No prices; not investment advice.
